SCHW
62
-2
ADSK
70
2
NOC
43
11
EQT
57
-2
XRAY
28
2
ZION
65
2
GPC
40
3
CFG
70
6
LLY
37
-3
MET
72
5
KMB
39
2
DE
63
3
M
37
12
CPB
30
6
INTU
56
-4
PG
56
5
HAS
33
3
CRM
67
2
EFX
38
2
NEE
50
-5
SCHW
62
-2
ADSK
70
2
NOC
43
11
EQT
57
-2
XRAY
28
2
ZION
65
2
GPC
40
3
CFG
70
6
LLY
37
-3
MET
72
5
KMB
39
2
DE
63
3
M
37
12
CPB
30
6
INTU
56
-4
PG
56
5
HAS
33
3
CRM
67
2
EFX
38
2
NEE
50
-5
Financhill
Back

WuXi Biologics (Cayman) 10K Form

Sell
22

WXXWY
WuXi Biologics (Cayman)

Last Price:
3.67
Seasonality Move:
-5.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WXXWY News And Ratings

See the #1 stock for the next 7 days that we like better than WXXWY

WXXWY Financial Statistics

Sales & Book Value

Annual Sales: $2.41B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $2.69
Price / Book: 1.35

Profitability

EPS (TTM): 0.16680
Net Income (TTM): $365.83M
Gross Margin: $965.27M
Return on Equity: 6.19%
Return on Assets: 4.8%

WuXi Biologics (Cayman) Earnings Forecast

Key WuXi Biologics (Cayman) Financial Ratios

  • The Gross Profit Margin over the past 10 years for WXXWY is 40.08%.
  • The Selling, General & Administrative Expenses for WXXWY have been equal to 10.50% of Gross Profit Margin.
  • The Research & Development expenses have been 4.61% of Revenue.
  • The Interest Expense is 4.66% of Operating Income.
  • The Net Earning history of WXXWY is 19.96% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 8 years.

WuXi Biologics (Cayman) Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: WXXWY
Website: wuxibiologics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 2.91
Quick Ratio: 2.4

Price-to-Earnings

Trailing P/E Ratio: 16.86
Forward P/E Ratio: 0

WXXWY Technical Analysis vs Fundamental Analysis

Sell
22
WuXi Biologics (Cayman) (WXXWY) is a Sell

Is WuXi Biologics (Cayman) a Buy or a Sell?